Introduction and Aims:
The introduction of the CKD-EPI and cystatin-C testing has been recommended in recent CKD guidance. The cost impact of this has not been studied in a primary care CKD cohort. We evaluated the cost impact of these guideline changes for UK primary care.
Methods:
We analysed the baseline cohort of the PSP-CKD study, a large UK primary care CKD clinical trial. A laboratory calculated MDRD eGFR<60 ml/min/1.73m 2 was the primary identifier for the cohort. Serum creatinine was also available. CKD-EPI (EPI) eGFR was recalculated from the serum creatinine. Costs were calculated using the criteria outlined in the 2014 NICE CKD guidance.
Results:
The records of 353,256 patients ≥18 years of age were analysed. 30,307 individuals had at least one MDRD eGFR<60 ml/min/1.73m 2 ('eGFR<60'). 20,166 (66.5%) had ≥2 MDRD eGFRs<60, >3 months apart. Of those with a single MDRD eGFR<60, 27,598 (91.1%) had a re-calculated CKD-EPI ('EPI') eGFR<60. Table 1 shows the numerical breakdown of the reclassification, with percentages representing the proportion reclassified to eGFR>60. Reclassification to EPI eGFR>60 was less likely in those with pre-existing second MDRD eGFR<60 (3.3% versus 11.1%, p<0.001). Extrapolating nationally, ~2% of the adult population could be eligible for a cystatin-C assay. Assuming similar results across the UK's adult population and at a conservative cost of £5.50 (€7.50) per test, the initial cost of implementing cystatin-C testing across the eligible CKD population would be £5.8 million (€7.9 million). This estimate does not include costs of interpretation and consequent changes to clinical management.
Conclusions:
Based on a large primary care CKD cohort, CKD stage reclassification using EPI is relatively infrequent, and occurs less often if a confirmatory MDRD eGFR is available. Up to 2% of the adult population and 60% of the stage 3A CKD population could require a cystatin-C measurement. Conservative cost estimates for this are high and further cost-benefit considerations of cystatin-C testing may be helpful.
